What is the recommended emergency department treatment for acute severe ulcerative colitis?

Emergency Department Treatment for Acute Severe Ulcerative Colitis

Hospitalized patients with acute severe ulcerative colitis should receive intravenous corticosteroids (methylprednisolone 60 mg daily or equivalent) as first-line treatment, combined with supportive care including VTE prophylaxis, and be assessed for response within 72 hours to determine need for rescue therapy with infliximab or cyclosporine. 1, 2

Initial Assessment and Supportive Care

Upon ED presentation, immediately:

• Exclude infections - Test for Clostridioides difficile and cytomegalovirus before initiating immunosuppression 2, 3
• Assess severity using Truelove-Witts criteria: ≥6 bloody stools/day PLUS one of: tachycardia >90 bpm, fever >37.8°C, hemoglobin <10.5 g/dL, or ESR >30 mm/h 2
• Rule out surgical emergencies - Free perforation, life-threatening hemorrhage, or generalized peritonitis require immediate surgical consultation 2

Critical supportive measures to initiate immediately:

• VTE prophylaxis with LMWH - IBD patients have exceptionally high thrombotic risk, especially when hospitalized 2, 4
• Bowel rest and IV fluids for resuscitation 2
• Nutritional support - Parenteral nutrition if emergency surgery anticipated 2
• Avoid routine antibiotics unless documented infection, abscess, or sepsis present 1, 2

First-Line Medical Treatment

Intravenous corticosteroids are the cornerstone of initial therapy 1, 5:

• Methylprednisolone 60 mg daily (or hydrocortisone equivalent) 4
• Continue for 3-5 days maximum 1
• Do NOT extend beyond 7 days - prolonged steroids without response increase surgical morbidity and mortality without benefit 1, 2

Response Assessment at 72 Hours

Evaluate treatment response on day 3 using clinical and biochemical markers 1, 4:

• Stool frequency, vital signs, hemoglobin
• Inflammatory markers (CRP, ESR)
• Approximately 66% respond to steroids; 34% will require colectomy 2

Rescue Therapy for Steroid-Refractory Disease

For patients not responding by day 3-5, initiate rescue therapy with either infliximab OR cyclosporine 1:

Infliximab

• 5 mg/kg IV infusion 1
• Reduces 90-day colectomy risk (RR 0.44) 1
• Preferred if patient already on immunosuppressives or needs long-term maintenance 6
• May consider intensified dosing in patients with high inflammatory burden or hypoalbuminemia 7, 8

Cyclosporine

• 2 mg/kg/day IV (lower dose has comparable efficacy to 4 mg/kg with better safety) 1
• Rapid onset of action, short half-life 6
• Preferred when imminent colectomy risk exists 6

Head-to-head trials show equivalent short-term colectomy rates between infliximab and cyclosporine (RR 1.00), with 5-year colectomy-free survival ~61-65% for both 1

Emerging Options

JAK inhibitors (tofacitinib, upadacitinib) show promise as adjunct or salvage therapy but evidence remains preliminary 7, 3, 8

Surgical Consultation and Timing

Early surgical consultation is mandatory - do not delay 2, 4:

Immediate surgery indicated for:

• Free perforation 2
• Life-threatening hemorrhage with hemodynamic instability 2
• Toxic megacolon with perforation, massive bleeding, or shock 2

Urgent surgery (24-48 hours) for:

• Toxic megacolon without clinical improvement after 24-48 hours of medical treatment 2
• Clinical deterioration at any point during medical therapy 2

Surgery after failed medical therapy:

• No improvement after 48-72 hours of first-line steroids - consider second-line therapy or surgery 2
• No response within 7 days of rescue therapy - proceed to colectomy 6

Subtotal colectomy with ileostomy is the procedure of choice for emergency surgery in ASUC 2

Critical Pitfalls to Avoid

• Delaying surgery in non-responders increases morbidity and mortality 2
• Prolonged IV immunosuppression (>7 days without response) worsens surgical outcomes 2
• Routine antibiotic use without documented infection is not beneficial 1
• Failure to provide VTE prophylaxis - this population has extremely high thrombotic risk 2
• Missing C. difficile or CMV before starting immunosuppression 2, 3

Multidisciplinary Approach

Management requires coordination between emergency medicine, gastroenterology, and surgery from admission 2, 4. Hemodynamically stable patients should have treatment decisions made jointly with gastroenterology, while unstable patients require immediate surgical intervention 2.